These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 18001147)

  • 21. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal.
    Oeuvray C; Theisen M; Rogier C; Trape JF; Jepsen S; Druilhe P
    Infect Immun; 2000 May; 68(5):2617-20. PubMed ID: 10768952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
    Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).
    Kangoye DT; Nebie I; Yaro JB; Debe S; Traore S; Ouedraogo O; Sanou G; Soulama I; Diarra A; Tiono A; Marsh K; Sirima SB; Bejon P
    PLoS One; 2014; 9(9):e107965. PubMed ID: 25238160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
    Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
    PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional Comparison of Blood-Stage
    Illingworth JJ; Alanine DG; Brown R; Marshall JM; Bartlett HE; Silk SE; Labbé GM; Quinkert D; Cho JS; Wendler JP; Pattinson DJ; Barfod L; Douglas AD; Shea MW; Wright KE; de Cassan SC; Higgins MK; Draper SJ
    Front Immunol; 2019; 10():1254. PubMed ID: 31214195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New antigens for a multicomponent blood-stage malaria vaccine.
    Osier FH; Mackinnon MJ; Crosnier C; Fegan G; Kamuyu G; Wanaguru M; Ogada E; McDade B; Rayner JC; Wright GJ; Marsh K
    Sci Transl Med; 2014 Jul; 6(247):247ra102. PubMed ID: 25080477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
    Dodoo D; Atuguba F; Bosomprah S; Ansah NA; Ansah P; Lamptey H; Egyir B; Oduro AR; Gyan B; Hodgson A; Koram KA
    Malar J; 2011 May; 10():108. PubMed ID: 21529376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development.
    Richards JS; Arumugam TU; Reiling L; Healer J; Hodder AN; Fowkes FJ; Cross N; Langer C; Takeo S; Uboldi AD; Thompson JK; Gilson PR; Coppel RL; Siba PM; King CL; Torii M; Chitnis CE; Narum DL; Mueller I; Crabb BS; Cowman AF; Tsuboi T; Beeson JG
    J Immunol; 2013 Jul; 191(2):795-809. PubMed ID: 23776179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02
    Berry AA; Gottlieb ER; Kouriba B; Diarra I; Thera MA; Dutta S; Coulibaly D; Ouattara A; Niangaly A; Kone AK; Traore K; Tolo Y; Mishcherkin V; Soisson L; Diggs CL; Blackwelder WC; Laurens MB; Sztein MB; Doumbo OK; Plowe CV; Lyke KE
    Malar J; 2019 Jan; 18(1):13. PubMed ID: 30658710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of hookworm infection and anthelmintic treatment on naturally acquired antibody responses against the GMZ2 malaria vaccine candidate and constituent antigens.
    Amoani B; Gyan B; Sakyi SA; Abu EK; Nuvor SV; Barnes P; Sarkodie-Addo T; Ahenkorah B; Sewor C; Dwomoh D; Theisen M; Cappello M; Wilson MD; Adu B
    BMC Infect Dis; 2021 Apr; 21(1):332. PubMed ID: 33832450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children.
    Sirima SB; Tiono AB; Ouédraogo A; Diarra A; Ouédraogo AL; Yaro JB; Ouédraogo E; Gansané A; Bougouma EC; Konaté AT; Kaboré Y; Traoré A; Chilengi R; Soulama I; Luty AJ; Druilhe P; Cousens S; Nébié I
    PLoS One; 2009 Oct; 4(10):e7549. PubMed ID: 19855847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children.
    Irani V; Ramsland PA; Guy AJ; Siba PM; Mueller I; Richards JS; Beeson JG
    Clin Infect Dis; 2015 Oct; 61(8):1244-52. PubMed ID: 26136391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytophilic Antibodies Against Key Plasmodium falciparum Blood Stage Antigens Contribute to Protection Against Clinical Malaria in a High Transmission Region of Eastern India.
    Kana IH; Garcia-Senosiain A; Singh SK; Tiendrebeogo RW; Chourasia BK; Malhotra P; Sharma SK; Das MK; Singh S; Adu B; Theisen M
    J Infect Dis; 2018 Aug; 218(6):956-965. PubMed ID: 29733355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
    Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months.
    Lusingu JP; Gesase S; Msham S; Francis F; Lemnge M; Seth M; Sembuche S; Rutta A; Minja D; Segeja MD; Bosomprah S; Cousens S; Noor R; Chilengi R; Druilhe P
    Malar J; 2009 Jul; 8():163. PubMed ID: 19607731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
    Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
    Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria.
    Courtin D; Oesterholt M; Huismans H; Kusi K; Milet J; Badaut C; Gaye O; Roeffen W; Remarque EJ; Sauerwein R; Garcia A; Luty AJ
    PLoS One; 2009 Oct; 4(10):e7590. PubMed ID: 19859562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.